Clinical trial
Evaluation of Antithrombotic STrategies in STEMI Patients in China
NCT03510832 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Antithrombotic STrategies in STEMI Patients in China
- Lead sponsor
- Qilu Hospital of Shandong University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 1, 2018
- Completion date
- December 31, 2021
- Enrollment
- 8,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
emergent pci, stemi